The gold standard technology for Circulating Cancer Cells
Gives patients more time by finding Circulating Cancer Cells in the blood long before metastasis can occur.
It has been demonstrated that CSC's circulate in blood months and years before the development of metastases. Thus their sensitive and diagnostic detection allow diagnosing invasive cancers early before the tumor mass becomes detectable by imaging. Allowing the opportunity to set up early treatment. Early detection avoids metastases and cancer recurrence.